Functional Diagnostics in Texas

Vigilant Biosciences is a biotechnology company specializing in early oral cancer detection through innovative point-of-care diagnostic technologies. Founded in 2011 and based in Lakeway, Texas, the company develops the BeVigilant OraFusion System, a patented non-invasive saliva-based test that detects multiple biomarkers clinically associated with early-stage oral cancer. The system has received FDA Breakthrough Device Designation and IVDR approval for international expansion. With annual revenue of $22 million and approximately 16-22 employees, Vigilant Biosciences primarily serves dental practitioners and healthcare providers seeking to improve oral cancer detection rates and patient outcomes. The company addresses a critical clinical need, as oral cancer—the sixth most common human cancer globally—currently has 5-year survival rates below 50%, with over 70% of cases diagnosed at advanced stages. The BeVigilant OraFusion System enables chairside screening with high accuracy, transforming detection and improving survival outcomes through early intervention.

Integrity Medical Products is a B2B supplier of medical equipment accessories, replacements, and consumables for healthcare facilities. The company specializes in patient monitoring cables and sensors (SpO2, ECG, invasive/non-invasive blood pressure) compatible with major monitor brands, available at 30–60% savings versus OEM pricing, with one-year warranties. Product portfolio includes monitor mounting arms and cable management systems (five-year warranty), nurse call accessories with pillow speakers (two-year warranty), medical carts and stands for monitors, ventilators, and suction pumps, and hospital furniture including overbed tables, bedside cabinets, fetal monitoring carts, bassinets, stools, and chairs with antimicrobial construction. Integrity also supplies suction and oxygen therapy products (analog and digital suction regulators, portable suction pumps, flowmeters, gas regulators, cylinder carts, high-pressure hoses) and offers patent-pending Integrated Flowmeter technology. Additional product lines include diagnostic systems (ophthalmoscopes/otoscopes with Welch Allyn compatibility), endoscopy/OR monitors and video accessories (wireless transmitters, fiber optic light cords, custom screen protectors), operating room table and stretcher pads (gel, foam, and self-adjusting air options for pressure ulcer prevention), and bed and stretcher accessories with custom fabrication available. The company targets hospitals, surgical centers, and critical care facilities, emphasizing affordability, compatibility with existing infrastructure, and practical solutions to institutional procurement challenges.

Healgen Scientific LLC is a global in-vitro diagnostics (IVD) developer and manufacturer established in 2007 in Houston, Texas. The company specializes in rapid point-of-care (POC) diagnostic testing technologies across multiple therapeutic areas: infectious diseases (COVID-19, influenza, Strep A), toxicology (drug screening, fentanyl/xylazine residue detection), fertility and women's health, oncology, cardiovascular, and metabolic disorders. Healgen's product portfolio includes rapid test cassettes, cups, and oral fluid devices—many FDA 510(k) cleared and CLIA-waived. Notable products include the Accurate® Multi-Drug Urine Drug Screen Cup (18-in-1 detection), Rapid Check® COVID-19/Flu A&B Antigen Test (available for both professional and OTC use), Fentanyl Rapid Tests, Strep A tests, and recently FDA De Novo-cleared Accurate® Oral Fluid Device. The company markets solutions to healthcare providers, workplace testing programs, public health organizations, and consumers. Healgen maintains global service centers and business partnerships across multiple countries and regions. Manufacturing and quality systems support FDA and international regulatory compliance.

Wegamed GmbH is a holistic medical technology company with 20+ years of experience in developing and distributing diagnostic and therapeutic wellness devices. The company specializes in non-invasive, drugless alternatives for health assessment and treatment, serving wellness professionals, clinics, and healthcare practitioners. Wegamed's product portfolio includes diagnostic devices (such as Prefit Bodyscan systems for comprehensive health analysis), therapeutic devices (Med Select for activating the body's self-healing mechanisms, and Med Matrix for whole-body detoxification), and wellness devices designed to support holistic health practices. All products are CE-certified medical devices and backed by clinical research. The company operates a comprehensive academy offering beginner and professional seminars for practitioners, and provides turnkey wellness hub solutions through Wegamed Wellness Center and Wellbeing Point offerings. Wegamed emphasizes identifying and treating underlying causes rather than symptom management, positioning its technology as a complement to conventional medical practice. The company serves international markets and works through partnerships with wellness professionals, clinics, and channel partners. Manufacturing and quality standards include TÜV certification and adherence to medical device regulations.

MedCAD is a Dallas-based medical technology company founded in 2007, specializing in patient-matched surgical devices and virtual surgical planning solutions. The company leverages advanced 3D imaging, CAD software, and precision manufacturing to design customized implants, surgical guides, and anatomical models for complex reconstructive and corrective procedures. Core offerings include the AccuPlan® Surgical Planning System for virtual surgical design, AccuPlate® 3D-printed titanium reconstruction plates, AccuShape® cranial implants in PEEK or titanium, AccuModel® anatomical models for surgical visualization, and AccuStride® foot and ankle surgical solutions. MedCAD serves cranial, maxillofacial, orthognathic, oral, plastic, and orthopedic surgery specialties. The company manufactures in-house in Texas with FDA clearance for its surgical products. MedCAD's approach combines engineer and design expertise—including trained sculptors and product designers—to create precision instruments and implants tuned to individual patient anatomy, enabling surgeons to plan procedures virtually, reduce operative time, and improve clinical outcomes.

Smart-ABI, developed by Hyperion Medical, is a cloud-based diagnostic solution specializing in Ankle Brachial Index (ABI) testing combined with Pulse Volume Recording (PVR) for the rapid, non-invasive diagnosis of Peripheral Artery Disease (PAD) and related vascular conditions. With over 25 years of medical device industry experience, the Smart-ABI platform delivers fast, simple, and accurate vascular assessments that integrate seamlessly into existing electronic medical record systems. The Smart-ABI Hub is a HIPAA-compliant software-as-a-service platform that enables mobile access, collaborative care between providers and specialists, and secure report transmission. The company's comprehensive vascular testing solutions—including the core Smart-ABI device and Smart-LEDA for combined ABI and sudomotor function assessment—are designed to improve early diagnosis of underdiagnosed PAD, reduce major cardiovascular and limb events, and support evidence-based clinical decision-making in diverse care settings.

Wenzel Spine, Inc. is a medical technology company founded in 2008 and headquartered in Austin, Texas, specializing in minimally invasive surgical solutions and diagnostic platforms for spinal disorders. The company is a recognized leader in stand-alone spine fusion technologies with over 17 years of expertise in expandable implant design and manufacturing. Wenzel Spine develops a comprehensive portfolio of devices designed to simplify spine surgery, reduce recovery time, and improve patient outcomes while preserving spinal anatomy and minimizing hardware burden. The company's mission emphasizes a "less is more" approach, often eliminating the need for supplemental fixation. With 21,000+ devices implanted, 11,000+ patients treated, and 300+ surgeon partners across North America and the European Union, Wenzel Spine maintains a strong commitment to ethical practices and regulatory compliance. The company serves orthopedic surgeons and spine specialists treating sacroiliac, lumbar, and cervical fusion patients through both innovative surgical systems and diagnostic software.

Aspira Women's Health is a diagnostic company specializing in AI-powered testing solutions for gynecologic care, with a focus on ovarian cancer risk stratification. The company develops and commercializes non-invasive biomarker-based tests for evaluating adnexal masses and personalizing ovarian cancer risk assessment. Their primary product portfolio, OvaSuite, includes OvaWatch (longitudinal monitoring for indeterminate/benign adnexal masses with reported >99% negative predictive value) and Ova1Plus (reflex testing combining biomarkers including CA-125, menopausal status, and ultrasound findings for surgical management decisions). Ova1Plus employs a two-step algorithm: Ova1 is performed first, and if intermediate risk is detected, Overa is automatically performed for increased specificity. Clinical evidence shows Ova1 detected malignancy risk in early-stage and premenopausal/postmenopausal cases where CA-125 was uninformative. The company emphasizes research-driven development with peer-reviewed publications supporting clinical utility. Products are FDA-cleared and positioned for use in conjunction with imaging and clinical assessment, not as standalone screening tools. Aspira targets obstetricians/gynecologists, gynecologic oncologists, primary care physicians, and hospital laboratories managing patients with adnexal masses.